We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





ERBA Mannheim Unveils Next-Generation Automation

By LabMedica International staff writers
Posted on 12 Aug 2019
Print article
Image: The NEXUS next-generation automation solution is designed for advanced automation across immunology, clinical chemistry and hematology (Photo courtesy of ERBA Mannheim).
Image: The NEXUS next-generation automation solution is designed for advanced automation across immunology, clinical chemistry and hematology (Photo courtesy of ERBA Mannheim).
ERBA Mannheim (London, UK) unveiled the Erba NEXUS next-generation automation solution at AACC 2019. Aimed at delivering mid-scale, advanced automation across immunology, clinical chemistry and hematology, the Erba NEXUS range employs advanced technology, including AI-based blood cell image analysis, advanced CLIA magnetic beads, thick film ISE analysis and an intuitive sample transport system, to deliver affordable modular automation.

The hematology system uses a unique combination of ultra-high definition imaging, AI and traditional methods to analyze thousands of blood cells per minute for improved turn-around time. The immunoassay system uses high sensitivity CLIA technology with proprietary magnetic bead design with a menu of over 100 parameters, while the chemistry system uses advanced thick-film ISE analysis technology and innovative reagent management to deliver improved workflow and enhanced analytical result quality.

Additionally, the company also exhibited the XL200 and XL640 – its signature chemistry analyzers which have been upgraded to include a touch screen with improved software for easier operation, longer walk-away time and faster TAT. Also on display at the tradeshow was the ELAN 30s – a new fully automated compact benchtop ELISA microstrip processor with easy to use software, including QC reports and the ability to simultaneously perform six different tests.

Among its existing suite of solutions featured at AACC 2019 was the LAURA XL fully automatic urine analyzer and the H560 and ELITE 580 fully automatic hematology analyzers. The company also showcased its new LIMS software with mobile app for providing high function device interfacing and remote online approval of patient reports, thus eliminating need for expensive LIS systems.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
High Performance Centrifuge
CO336/336R
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.